Today: 16 March 2026
Subscribe
Browse Category

NYSE:UNH 5 February 2026 - 5 March 2026

UnitedHealth stock price ticks up after hours as UNH files shelf, 10-K and accounting shake-up

UnitedHealth stock price ticks up after hours as UNH files shelf, 10-K and accounting shake-up

UnitedHealth Group shares rose 0.5% after hours Monday to $294.93 following new SEC filings. The company registered a shelf for potential securities offerings and named Dennis Stankiewicz chief accounting officer, replacing Tom Roos, who moves to Optum Insight. UnitedHealthcare expects Medicare Advantage membership to shrink in 2026. Optum Rx’s 2025 drug spend reached $188 billion.
3 March 2026
·
UnitedHealth stock today: UNH rises on dividend return as Medicare Advantage rates near a key deadline

UnitedHealth stock today: UNH rises on dividend return as Medicare Advantage rates near a key deadline

UnitedHealth Group shares rose 1.72% to $291.60 by 11:44 a.m. EST Friday, outperforming a weaker market. The company authorized a $2.21 quarterly dividend, payable March 17. Medicare Advantage enrollment fell in seven states for 2026, with UnitedHealth’s count down over 5% but still leading at 9.3 million. The final 2027 Medicare Advantage rate announcement is expected by April 6.
27 February 2026
··
Dow Jones today: DJIA rises 300 points with Nvidia earnings in the crosshairs

Dow Jones today: DJIA rises 300 points with Nvidia earnings in the crosshairs

The Dow rose 307.8 points to 49,482.3 in early afternoon trading Wednesday. Investors awaited Nvidia’s quarterly report, with options markets pricing a 5.6% post-earnings move, the smallest in three years. IBM climbed over 4%, while Axon Enterprise jumped on strong earnings. GoDaddy and Lowe’s fell after weak forecasts.
25 February 2026
···········
UnitedHealth stock holds near $290 as CMS Medicare Advantage deadline looms

UnitedHealth stock holds near $290 as CMS Medicare Advantage deadline looms

UnitedHealth shares closed Friday up 0.02% at $290.00, then slipped 0.28% after hours. Investors are watching for Medicare Advantage policy updates, with a federal comment deadline set for Feb. 25 and a final rate decision expected by April 6. CMS projects a 0.09% average payment increase for 2027. UnitedHealth outperformed peers as Cigna, Elevance, CVS, and Humana all fell.
22 February 2026
·
Dow Jones at 49,500 after softer CPI — what to watch before Wall Street’s next session

Dow Jones at 49,500 after softer CPI — what to watch before Wall Street’s next session

The Dow closed up 48.95 points at 49,500.93 Friday but posted a 1.2% weekly drop, its biggest since November. January’s core CPI rose 0.3%, the smallest annual gain in nearly five years, sending the 10-year Treasury yield down to 4.05%. Traders now see a 52.3% chance of a Fed rate cut in June. The NYSE will be closed Monday for Washington’s Birthday.
14 February 2026
······
UnitedHealth (UNH) stock price rises as markets slide — Medicare Advantage deadlines and Humana warning in focus

UnitedHealth (UNH) stock price rises as markets slide — Medicare Advantage deadlines and Humana warning in focus

UnitedHealth shares climbed nearly 2% to $284.37 Thursday, bucking a broad market selloff as investors focused on Medicare Advantage policy signals. Humana warned of a 2026 profit hit from lower Medicare Advantage “star” ratings, missing analyst expectations. All major U.S. indexes fell over 1%. Key Medicare rate decisions are due Feb. 25 and April 6.
12 February 2026
··
UnitedHealth stock price today: UNH ticks up as Medicare Advantage rate clock and ACA probes hang over insurers

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rate clock and ACA probes hang over insurers

UnitedHealth shares rose 0.8% to $278.04 Tuesday after a volatile open, as investors watched Medicare Advantage payment updates and new federal scrutiny of health insurers. The Centers for Medicare & Medicaid Services projected a 0.09% average payment increase for 2027, with final rates due by April 6. House Republicans subpoenaed eight ACA insurers in a subsidy fraud probe; UnitedHealth was not named. Managed care stocks were mixed.
10 February 2026
·
UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth shares slipped 0.3% to $275.70 in after-hours trading Monday, while the S&P 500 and Nasdaq closed higher. Healthcare stocks lagged as investors eyed Medicare Advantage reimbursement and cost trends ahead of key policy updates. Humana dropped 2.3%, CVS Health fell 3.3%, and Cigna rose 0.8%. UnitedHealth last month warned of its first revenue decline in decades if proposed Medicare rates hold.
10 February 2026
····
UnitedHealth stock price today: UNH ticks up as Medicare Advantage rates and U.S. data loom

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rates and U.S. data loom

UnitedHealth shares rose 0.3% to $277.44 in late morning trading Monday after CMS signaled a 0.09% Medicare Advantage payment increase for 2027. The stock remains under pressure after a 19% drop on Jan. 27, when the company warned of its first revenue decline since 1989. U.S. stocks were mixed, with the Dow down 0.3%. Comments on the CMS proposal are due by Feb. 25.
9 February 2026
··
UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth shares rose 3% Friday to $276.65 after a volatile week for managed-care stocks. Investors await insurer earnings from CVS Health on Feb. 10 and Humana on Feb. 11 for updates on Medicare Advantage trends. The Centers for Medicare and Medicaid Services has proposed a 0.09% payment increase for 2027 plans. The comment period on the 2027 rate notice closes Feb. 25.
8 February 2026
···
UnitedHealth stock price ticks up to $276.65 as insurer cost signals shift — what investors watch next week

UnitedHealth stock price ticks up to $276.65 as insurer cost signals shift — what investors watch next week

UnitedHealth shares closed up 3% at $276.65 Friday, rebounding after Molina Healthcare’s weak 2026 outlook rattled managed-care stocks. Centene later issued a stronger 2026 profit forecast, easing some pressure. UnitedHealth traded between $263.00 and $277.74 during the session. Investors await Humana’s results Feb. 11 and a Medicare Advantage rate decision April 6.
7 February 2026
·
UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth shares rose 3.4% to $277.57 Friday and gained another 3% after hours, rebounding after a volatile week for health insurers. Mizuho cut its price target on the stock to $350, citing delayed earnings recovery. Medicare Advantage rates and medical-cost trends remain key concerns. The Dow closed above 50,000, marking the strongest market gains in months.
7 February 2026
····
UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth (UNH) stock rebounds nearly 2% as sector digests cost shock, Mizuho trims target

UnitedHealth shares rose 1.9% to $273.79 Friday, rebounding after Molina Healthcare’s weak 2026 profit outlook sent sector stocks tumbling Thursday. Mizuho cut its price target for UnitedHealth to $350 but kept an Outperform rating. Investors await the April 6 CMS decision on 2027 Medicare Advantage rates. Molina shares plunged nearly 28%, while Centene fell 5.5% and Cigna gained about 3%.
6 February 2026
·
1 2 3 … 9

Stock Market Today

  • Diageo shares plunge 21.7% in three weeks; £15,000 investment falls to £11,746
    March 16, 2026, 12:04 PM EDT. Diageo (LSE: DGE) shares have plunged to a 52-week low, dropping 21.7% since February 24 amid slow sales in North America and China and a 50% dividend cut. A £15,000 investment three weeks ago would now be worth around £11,746. The company faces challenges from shifting drinking habits and a consumer shift toward cheaper spirits, undermining its premiumisation strategy. However, Guinness sales rose 10.9% overall, with non-alcoholic versions gaining popularity. Market watchers note Guinness's strength could prompt a spin-off worth an estimated £10 billion, representing a significant portion of Diageo's £33 billion market value. Investors should weigh risks before considering Diageo shares at current levels.
Go toTop